Fitness costs and diversity of the cytotoxic T lymphocyte (CTL) response determine the rate of CTL escape during acute and chronic phases of HIV infection

Journal of Virology

Volumn 85, Issue 20, 2011, Pages 10518-10528

  Ganusov, Vitaly V ^a,e   Goonetilleke, Nilu ^b   Liu, Michael K P ^b   Ferrari, Guido ^g   Shaw, George M ^c   McMichael, Andrew J ^b   Borrow, Persephone ^d   Korber, Bette T ^a,f   Perelson, Alan S ^a  

^a LOS ALAMOS NATIONAL LABORATORY   (United States)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e UNIVERSITY OF TENNESSEE   (United States)

^f SANTA FE INSTITUTE   (United States)

^g DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE;

ARTICLE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DISEASE COURSE; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE EVASION; MATHEMATICAL MODEL; PRIORITY JOURNAL; VIRUS MUTATION; VIRUS REPLICATION;

CYTOTOXICITY, IMMUNOLOGIC; EPITOPES, T-LYMPHOCYTE; HIV INFECTIONS; HIV-1; HUMANS; IMMUNE EVASION; T-LYMPHOCYTES, CYTOTOXIC; VIRULENCE; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 80055017715     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00655-11     Document Type: Article

References (99)

1. Addo, M., et al. 2003. Comprehensive epitope analysis of human immunodeficiency virus type 1 (HIV-1)-specific T-cell responses directed against the entire expressed HIV-1 genome demonstrate broadly directed responses, but no correlation to viral load. J. Virol. 77:2081-2092.
2. Ahmed, R. 1996. Tickling memory T cells. Science 272:1904.
3. Allen, T., et al. 2004. Selection, transmission, and reversion of an antigenprocessing cytotoxic T-lymphocyte escape mutation in human immunodeficiency virus type 1 infection. J. Virol. 78:7069-7078.
4. Allen, T. M., et al. 2000. Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia. Nature 407:386-390.
5. Allen, T. M., et al. 2005. De novo generation of escape variant-specific CD8+ T-cell responses following cytotoxic T-lymphocyte escape in chronic human immunodeficiency virus type 1 infection. J. Virol. 79:12952-12960.
6. Althaus, C., and R. De Boer. 2008. Dynamics of immune escape during HIV/SIV infection. PLoS Comput. Biol. 4:e1000103.
7. Althaus, C., V. Ganusov, and R. De Boer. 2007. Dynamics of CD8+ T cell responses during acute and chronic lymphocytic choriomeningitis virus infection. J. Immunol. 179:2944-2951.
8. Asquith, B. 2008. The evolutionary selective advantage of HIV-1 escape variants and the contribution of escape to the HLA-associated risk of AIDS progression. PLoS One 3:e3486.
9. Asquith, B., C. Edwards, M. Lipsitch, and A. McLean. 2006. Inefficient cytotoxic T lymphocyte-mediated killing of HIV-1-infected cells in vivo. PLoS Biol. 4:e90.
10. Asquith, B., and A. McLean. 2007. In vivo CD8+ T cell control of immunodeficiency virus infection in humans and macaques. Proc. Natl. Acad. Sci U. S. A. 104:6365-6370.
11. Asquith, B., et al. 2007. In vivo T lymphocyte dynamics in humans and the impact of human T-lymphotropic virus 1 infection. Proc. Natl. Acad. Sci. U. S. A. 104:8035-8040.
12. Balagam, R., V. Singh, A. R. Sagi, and N. M. Dixit. 2011. Taking multiple infections of cells and recombination into account leads to small within-host effective-population-size estimates of HIV-1. PLoS One 6:e14531.
13. Balamurali, M., et al. 2010. Does cytolysis by CD8+ T cells drive immune escape in HIV infection? J. Immunol. 185:5093-5101.
14. Barouch, D., J. Kunstman, J. Glowczwskie, K. Kunstman, M. Egan, et al. 2003. Viral escape from dominant simian immunodeficiency virus epitopespecific cytotoxic T lymphocytes in DNA-vaccinated rhesus monkeys. J. Virol. 77:7367-7375.
15. Barouch, D., et al. 2002. Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes. Nature 415:335-339.
16. Barouch, D., et al. 2000. Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination. Science 290: 486-492.
17. Barouch, D. H., and B. Korber. 2010. HIV-1 vaccine development after STEP. Annu. Rev. Med. 61:153-167.
18. Bates, D. M., and D. G. Watts. 1988. Nonlinear regression analysis and its applications. John Wiley & Sons, Inc., New York, NY.
19. Bolitho, P., I. Voskoboinik, J. A. Trapani, and M. J. Smyth. 2007. Apoptosis induced by the lymphocyte effector molecule perforin. Curr. Opin. Immunol. 19:339-347.
20. Borrow, P., et al. 1997. Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus. Nat. Med. 3:205-211.
21. Casimiro, D. R., et al. 2005. Attenuation of simian immunodeficiency virus SIVmac239 infection by prophylactic immunization with DNA and recombinant adenoviral vaccine vectors expressing Gag. J. Virol. 79:15547-15555.
22. Chung, C., et al. 2007. Not all cytokine-producing CD8+ T cells suppress simian immunodeficiency virus replication. J. Virol. 81:1517-1523.
23. Cocchi, F., et al. 1995. Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells. Science 270:1811-1815.
24. Corey, L., M. J. McElrath, and J. G. Kublin. 2009. Post-step modifications for research on HIV vaccines. AIDS 23:3-8.
25. Crawford, H., et al. 2009. Evolution of HLA-B*5703 HIV-1 escape mutations in HLA-B*5703-positive individuals and their transmission recipients. J. Exp. Med. 206:909-921.
26. Davenport, M. P., L. Loh, J. Petravic, and S. J. Kent. 2008. Rates of HIV immune escape and reversion: implications for vaccination. Trends Microbiol. 16:561-566.
27. De Boer, R. J., and A. S. Perelson. 1995. Towards a general function describing T cell proliferation. J. Theor. Biol. 175:567-576.
28. Draenert, R., et al. 2004. Immune selection for altered antigen processing leads to cytotoxic T lymphocyte escape in chronic HIV-1 infection. J. Exp. Med. 199:905-915.
29. Efron, B., and R. Tibshirani. 1993. Introduction to the bootstrap. Chapman & Hall, New York, NY.
30. Fernandez, C., et al. 2005. Rapid viral escape at an immunodominant simianhuman immunodeficiency virus cytotoxic T-lymphocyte epitope exacts a dramatic fitness cost. J. Virol. 79:5721-5731.
31. Ferrari, G., et al. 2011. Relationship between functional profile of HIV-1 specific CD8 T cells and epitope variability with the selection of escape mutants in acute HIV-1 infection. PLoS Pathog. 7:e1001273.
32. Fischer, W., V. V. Ganusov, E. E. Giorgi, P. T. Hraber, B. F. Keele, et al. 2010. Transmission of single HIV-1 genomes and dynamics of early immune escape revealed by ultra-deep sequencing. PLoS One 5:e12303.
33. Frater, A. J., et al. 2007. Effective T-cell responses select human immunodeficiency virus mutants and slow disease progression. J. Virol. 81:6742-6751.
34. Fryer, H. R., A. Scherer, A. Oxenius, R. Phillips, and A. R. McLean. 2009. No evidence for competition between cytotoxic T-lymphocyte responses in HIV-1 infection. Proc. Biol. Sci. 276:4389-4397.
35. Ganusov, V., and R. De Boer. 2006. Estimating costs and benefits of CTL escape mutations in SIV/HIV infection. PLoS Comput. Biol. 2:e24.
36. Ganusov, V., and R. De Boer. 2007. Do most lymphocytes in humans really reside in the gut? Trends Immunol. 28:514-518.
37. Ganusov, V. V., D. L. Barber, and R. J. De Boer. 2011. Killing of targets by CD8 T cells in the mouse spleen follows the law of mass action. PLoS One 6:e15959.
38. Gasper-Smith, N., et al. 2008. Induction of plasma (TRAIL), TNFR-2, Fas ligand, and plasma microparticles after human immunodeficiency virus type 1 (HIV-1) transmission: implications for HIV-1 vaccine design. J. Virol. 82:7700-7710.
39. Gay, C., et al. 2011. Cross-sectional detection of acute HIV infection: timing of transmission, inflammation and antiretroviral therapy. PLoS One 6:e19617.
40. Geels, M., et al. 2003. Identification of sequential viral escape mutants associated with altered T-cell responses in a human immunodeficiency virus type 1-infected individual. J. Virol. 77:12430-12440.
41. Goonetilleke, N., et al. 2009. The first T cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infection. J. Exp. Med. 206:1253-1272.
42. Goulder, P., and D. Watkins. 2004. HIV and SIV CTL escape: implications for vaccine design. Nat. Rev. Immunol. 4:630-640.
43. Goulder, P. J., et al. 1997. Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS. Nat. Med. 3:212-217.
44. Gray, C. M., et al. 2009. Human immunodeficiency virus-specific gamma interferon enzyme-linked immunospot assay responses targeting specific regions of the proteome during primary subtype C infection are poor predictors of the course of viremia and set point. J. Virol. 83:470-478.
45. Guidotti, L. G., and F. V. Chisari. 2001. Noncytolytic control of viral infections by the innate and adaptive immune response. Annu. Rev. Immunol. 19:65-91.
46. Hay, C., et al. 1999. Lack of viral escape and defective in vivo activation of human immunodeficiency virus type 1-specific cytotoxic T lymphocytes in rapidly progressive infection. J. Virol. 73:5509-5519.
47. Jones, N. A., et al. 2004. Determinants of human immunodeficiency virus type 1 escape from the primary CD8+ cytotoxic T lymphocyte response. J. Exp. Med. 200:1243-1256.
48. Kaur, A., et al. 2001. Emergence of cytotoxic T lymphocyte escape mutations in nonpathogenic simian immunodeficiency virus infection. Eur. J. Immunol. 31:3207-3217.
49. Kawada, M., et al. 2006. Involvement of multiple epitope-specific cytotoxic T-lymphocyte responses in vaccine-based control of simian immunodeficiency virus replication in rhesus macaques. J. Virol. 80:1949-1958.
50. Keele, B. F., et al. 2008. Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection. Proc. Natl. Acad. Sci. U. S. A. 105:7552-7557.
51. Kent, S., C. Fernandez, C. Dale, and M. Davenport. 2005. Reversion of immune escape HIV variants upon transmission: insights into effective viral immunity. Trends Microbiol. 13:243-246.
52. Kirchherr, J. L., et al. 2007. High throughput functional analysis of HIV-1 env genes without cloning. J. Virol. Methods 143:104-111.
53. Klatt, N. R., et al. 2010. CD8+ lymphocytes control viral replication in SIVmac239-infected rhesus macaques without decreasing the lifespan of productively infected cells. PLoS Pathog. 6:e1000747.
54. Koenig, S., et al. 1995. Transfer of HIV-1-specific cytotoxic T lymphocytes to an AIDS patient leads to selection for mutant HIV variants and subsequent disease progression. Nat. Med. 1:330-336.
55. Kouyos, R., C. Althaus, and S. Bonhoeffer. 2006. Stochastic or deterministic: what is the effective population size of HIV-1? Trends Microbiol. 14:507-511.
56. Leslie, A., et al. 2004. HIV evolution: CTL escape mutation and reversion after transmission. Nat. Med. 10:282-289.
57. Levy, J. 2003. The search for the CD8+ cell anti-HIV factor (CAF). Trends Immunol. 24:628-632.
58. Little, S. J., A. R. McLean, C. A. Spina, D. D. Richman, and D. V. Havlir. 1999. Viral dynamics of acute HIV-1 infection. J. Exp. Med. 190:841-850.
59. Liu, J., et al. 2009. Immune control of an SIV challenge by a T-cell-based vaccine in rhesus monkeys. Nature 457:87-91.
60. Liu, Y., and J. E. Mittler. 2008. Selection dramatically reduces effective population size in HIV-1 infection. BMC Evol. Biol. 8:133.
61. Liu, Y., J. I. Mullins, and J. E. Mittler. 2006. Waiting times for the appearance of cytotoxic T-lymphocyte escape mutants in chronic HIV-1 infection. Virology 347:140-146.
62. Liu, Y., et al. 2004. Molecular clock-like evolution of human immunodeficiency virus type 1. Virology 329:101-108.
63. Loffredo, J. T., et al. 2007. The antiviral efficacy of simian immunodeficiency virus-specific CD8+ T cells is unrelated to epitope specificity and is abrogated by viral escape. J. Virol. 81:2624-2634.
64. Loh, L., J. Petravic, C. Batten, M. Davenport, and S. Kent. 2008. Vaccination and timing influence SIV immune escape viral dynamics in vivo. PLoS Pathog. 4:e12.
65. Mandl, J. N., R. R. Regoes, D. A. Garber, and M. B. Feinberg. 2007. Estimating the effectiveness of simian immunodeficiency virus-specific CD8+ T cells from the dynamics of viral immune escape. J. Virol. 81:11982-11991.
66. Mansky, L. M. 1996. Forward mutation rate of human immunodeficiency virus type 1 in a T lymphoid cell line. AIDS Res. Hum. Retroviruses 12:307-314.
67. Markowitz, M., et al. 2003. A novel antiviral intervention results in more accurate assessment of human immunodeficiency virus type 1 replication dynamics and T-cell decay in vivo. J. Virol. 77:5037-5038.
68. Martinez-Picado, J., et al. 2006. Fitness cost of escape mutations in p24 Gag in association with control of human immunodeficiency virus type 1. J. Virol. 80:3617-3623.
69. McDermott, A. B., et al. 2005. Cytotoxic T-lymphocyte escape does not always explain the transient control of simian immunodeficiency virus SIVmac239 viremia in adenovirus-boosted and DNA-primed Mamu-A*01-positive rhesus macaques. J. Virol. 79:15556-15566.
70. McMichael, A. J., P. Borrow, G. D. Tomaras, N. Goonetilleke, and B. F. Haynes. 2010. The immune response during acute HIV-1 infection: clues for vaccine development. Nat. Rev. Immunol. 10:11-23.
71. Mehandru, S., et al. 2004. Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract. J. Exp. Med. 200:761-770.
72. Mehandru, S., et al. 2007. Mechanisms of gastrointestinal CD4+ T-cell depletion during acute and early human immunodeficiency virus type 1 infection. J. Virol. 81:599-612.
73. Migueles, S. A., et al. 2008. Lytic granule loading of CD8(+) T cells is required for HIV-infected cell elimination associated with immune control. Immunity 29:1009-1021.
74. Miura, T., et al. 2009. HLA-B57/B*5801 human immunodeficiency virus type 1 elite controllers select for rare Gag variants associated with reduced viral replication capacity and strong cytotoxic T-lymphocyte recognition. J. Virol. 83:2743-2755.
75. Monteiro, L., C. Goncalves, and J. Piqueira. 2000. A condition for successful escape of a mutant after primary HIV infection. J. Theor. Biol. 203:399-406.
76. Neher, R. A., and T. Leitner. 2010. Recombination rate and selection strength in HIV intra-patient evolution. PLoS Comput. Biol. 6:e1000660.
77. Nowak, M. 1996. Immune responses against multiple epitopes: a theory for immunodominance and antigenic variation. Semin. Virol. 7:83-92.
78. Nowak, M., et al. 1995. HIV results in the frame: results confirmed. Nature 375:193.
79. Nowak, M. A., et al. 1991. Antigenic diversity thresholds and the development of AIDS. Science 254:963-969.
80. O'Connor, D. H., et al. 2002. Acute phase cytotoxic T lymphocyte escape is a hallmark of simian immunodeficiency virus infection. Nat. Med. 8:493-499.
81. Perelson, A. S., C. Macken, E. Grimm, L. Roos, and B. Bonavida. 1984. Mechanism of cell-mediated cytotoxicity at the single cell level. VIII. Kinetics of lysis of target cells bound by more than one cytotoxic T lymphocyte. J. Immunol. 132:2190-2198.
82. Perelson, A. S., A. U. Neumann, M. Markowitz, J. M. Leonard, and D. D. Ho. 1996. HIV-1 dynamics in vivo: virion clearance rate, infected cell lifespan, and viral generation time. Science 271:1582-1586.
83. Petravic, J., L. Loh, S. Kent, and M. Davenport. 2008. CD4+ target cell availability determines the dynamics of immune escape and reversion in vivo. J. Virol. 82:4091-4101.
84. Petravic, J., et al. 2008. Estimating the impact of vaccination on acute simian-human immunodeficiency virus/simian immunodeficiency virus infections. J. Virol. 82:11589-11598.
85. Peyerl, F. W., et al. 2004. Fitness costs limit viral escape from cytotoxic T lymphocytes at a structurally constrained epitope. J. Virol. 78:13901-13910.
86. Prado, J. G., et al. 2009. Functional consequences of human immunodeficiency virus escape from an HLA-B*13-restricted CD8+ T-cell epitope in p1 Gag protein. J. Virol. 83:1018-1025.
87. Price, D. A., et al. 1998. Antigen-specific release of beta-chemokines by anti-HIV-1 cytotoxic T lymphocytes. Curr. Biol. 8:355-358.
88. Ramratnam, B., et al. 1999. Rapid production and clearance of HIV-1 and hepatitis C virus assessed by large volume plasma apheresis. Lancet 354: 1782-1785.
89. Regoes, R., D. Barber, R. Ahmed, and R. Antia. 2007. Estimation of the rate of killing by cytotoxic T lymphocytes in vivo. Proc. Natl. Acad. Sci. U. S. A. 104:1599-1603.
90. Reynolds, M. R., et al. 2008. Macaques vaccinated with live-attenuated SIV control replication of heterologous virus. J. Exp. Med. 205:2537-2550.
91. Ribeiro, R. M., et al. 2010. Estimation of the initial viral growth rate and basic reproductive number during acute HIV-1 infection. J. Virol. 84:6096-6102.
92. Troyer, R. M., et al. 2009. Variable fitness impact of HIV-1 escape mutations to cytotoxic T lymphocyte (CTL) response. PLoS Pathog. 5:e1000365.
93. Turnbull, E. L., et al. 2009. Kinetics of expansion of epitope-specific T cell responses during primary HIV-1 infection. J. Immunol. 182:7131-7145.
94. Valentine, L. E., et al. 2008. Recognition of escape variants in ELISPOT does not always predict CD8+ T-cell recognition of simian immunodeficiency virus-infected cells expressing the same variant sequences. J. Virol. 82:575-581.
95. Wagner, L., et al. 1998. Beta-chemokines are released from HIV-1-specific cytolytic T-cell granules complexed to proteoglycans. Nature 391:908-911.
96. Wang, Y. E., et al. 2009. Protective HLA class I alleles that restrict acutephase CD8+ T-cell responses are associated with viral escape mutations located in highly conserved regions of human immunodeficiency virus type 1. J. Virol. 83:1845-1855.
97. Wherry, E., J. Blattman, K. Murali-Krishna, R. Van Der Most, and R. Ahmed. 2003. Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment. J. Virol. 77:4911-4927.
98. Wong, J. K., et al. 2010. In vivo CD8+ T-cell suppression of SIV viremia is not mediated by CTL clearance of productively infected cells. PLoS Pathog. 6:e1000748.
99. Zhang, L., et al. 1999. Rapid clearance of simian immunodeficiency virus particles from plasma of rhesus macaques. J. Virol. 73:855-860.